Caribou Biosciences
Caribou Biosciences
cariboubio.com

Locations

Berkeley, CA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Other

founded in

2011

Caribou is a clinical-stage biopharmaceutical company, founded by pioneers in CRISPR genome editing, leveraging our proprietary technology to develop genome-edited off-the-shelf immune cell therapies for the treatment of cancer. We believe that cell therapies are critical now and for the future of cancer therapy and that advanced genome editing is necessary to develop sophisticated cell therapies to treat a variety of malignancies. We are developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for a range of tumor types.

Something looks off?
Open jobs at Caribou Biosciences
Powered by Getro